TY - JOUR
T1 - Glucagon and Blood Sugar
AU - Swenson, Keith H.
AU - Alsever, Robert N.
AU - Sherwin, Robert S.
AU - Felig, Philip
AU - Unger, Roger H
AU - Levine, Rachmiel
PY - 1976/5/27
Y1 - 1976/5/27
N2 - To the Editor: Sherwin et al., in their article (N Engl J Med 294: 455–461, 1976), and Levine, in his editorial (N Engl J Med 294: 494–495, 1976), concude that glucagon exerts a diabetogenic action only when there is insulin deficiency and not in the normal patient. This point of view is not consistent with findings in the glucagonoma syndrome, which is a rare clinical condition characterized by the association of a distinctive cutaneous eruption with a glucagon-secreting islet-cell neoplasm of the pancreas. Typically, these patients exhibit a diabetic glucose tolerance curve presumably related to high circulating glucagon levels.
AB - To the Editor: Sherwin et al., in their article (N Engl J Med 294: 455–461, 1976), and Levine, in his editorial (N Engl J Med 294: 494–495, 1976), concude that glucagon exerts a diabetogenic action only when there is insulin deficiency and not in the normal patient. This point of view is not consistent with findings in the glucagonoma syndrome, which is a rare clinical condition characterized by the association of a distinctive cutaneous eruption with a glucagon-secreting islet-cell neoplasm of the pancreas. Typically, these patients exhibit a diabetic glucose tolerance curve presumably related to high circulating glucagon levels.
UR - http://www.scopus.com/inward/record.url?scp=0017065782&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017065782&partnerID=8YFLogxK
U2 - 10.1056/NEJM197605272942218
DO - 10.1056/NEJM197605272942218
M3 - Letter
C2 - 177868
AN - SCOPUS:0017065782
SN - 0028-4793
VL - 294
SP - 1238
EP - 1240
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 22
ER -